Molecular interactions between complement factor H and its heparin and heparan sulfate ligands

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Perkins, Stephen J ^a   Fung, Ka Wai ^a   Khan, Sanaullah ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Analytical ultracentrifugation; Complement factor H; Heparan sulfate; Heparin; Surface plasmon resonance; X ray scattering

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; HEPARAN SULFATE; HEPARIN; LIGAND; OLIGOSACCHARIDE;

BINDING AFFINITY; BINDING SITE; BIOPHYSICS; CARBOHYDRATE ANALYSIS; CELL SURFACE; CHEMICAL STRUCTURE; COMPLEMENT ACTIVATION; DISSOCIATION CONSTANT; GENE MUTATION; GENETIC POLYMORPHISM; HEMOLYTIC UREMIC SYNDROME; HOST CELL; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PROTEIN DATA BANK; RADIATION SCATTERING; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SEDIMENTATION RATE; SURFACE PLASMON RESONANCE; ULTRACENTRIFUGATION; X RAY CRYSTALLOGRAPHY;

EID: 84897953538     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00126     Document Type: Review

References (54)

1. Walport MJ. Complement. N Engl J Med (2001) 344:1058-66 1140-44. doi:10.1056/NEJM200104053441406
2. Law SKA, Reid KBM. Complement. 2nd ed. Oxford: IRL Press (1995).
3. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol (2009) 9:729-40. doi:10.1038/nri2620
4. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 11:785-97. doi:10.1038/ni.1923
5. Okemefuna AI, Stach L, Rana S, Ziai Buetas AJ, Gor J, Perkins SJ. C-reactive protein exists in an NaCl concentration dependent pentamer-decamer equilibrium in physiological buffer. J Biol Chem (2010) 285:1041-52. doi:10.1074/jbc.M109.044495
6. Okemefuna AI, Nan R, Miller A, Gor J, Perkins SJ. Complement factor H binds at two independent sites to C-reactive protein in acute-phase concentrations. J Biol Chem (2010) 285:1053-65. doi:10.1074/jbc.M109.044529
7. Coombe DR, Kett WC. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci (2005) 62:410-24. doi:10.1007/s00018-004-4293-7
8. Khan S, Gor J, Mulloy B, Perkins SJ. Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. J Mol Biol (2010) 395:504-21. doi:10.1016/j.jmb.2009.10.064
9. Khan S, Gor J, Mulloy B, Perkins SJ. Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. J Mol Biol (2013) 425:1847. doi:10.1016/j.jmb.2009.10.064
10. Khan S, Nan R, Gor J, Mulloy B, Perkins SJ. Bivalent and co-operative binding of complement factor H to heparan sulphate and heparin. Biochem J (2012) 444:417-28. doi:10.1042/BJ20120183
11. Langdown J, Belzar KJ, Savory WJ, Baglin TP, Huntington JA. The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin. J Mol Biol (2009) 386:1278-89. doi:10.1016/j.jmb.2009.01.028
12. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature (2000) 407:1029-34. doi:10.1038/35039551
13. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell (2000) 6:743-50. doi:10.1016/S1097-2765(00)00073-3
14. Khan S, Fung KW, Rodriguez E, Patel R, Gor J, Mulloy B, et al. The solution structure of heparan sulphate differs from that of heparin: implications for function. J Biol Chem (2013) 288:27737-51. doi:10.1074/jbc.M113.492223
15. Khan S, Rodriguez E, Patel R, Gor J, Mulloy B, Perkins SJ. The solution structure of heparan sulphate differs from that of heparin: implications for function. J Biol Chem (2011) 286:24842-54. doi:10.1074/jbc.M111.226027
16. Lütteke T. Analysis and validation of carbohydrate three-dimensional structures. Acta Crystallogr D Biol Crystallogr (2009) 65:156-68. doi:10.1107/S0907444909001905
17. Lütteke T, von der Lieth CW. pdb-care (PDB carbohydrate residue check): a program to support annotation of complex carbohydrate structures in PDB files. BMC Bioinformatics (2004) 5:69. doi:10.1186/1471-2105-5-69
18. Schmidt CQ, Herbert AP, Kavanagh D, Gandy C, Fenton CJ, Blaum BS, et al. A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol (2008) 181:2610-9.
19. Sharma AK, Pangburn MK. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl Acad Sci U S A (1996) 93:10996-1001. doi:10.1073/pnas.93.20.10996
20. Jokiranta TS, Hellwage J, Koistinen V, Zipfel PF, Meri S. Each of the three binding sites of factor H interacts with a distinct site on C3b. J Biol Chem (2000) 275:27657-62. doi:10.1074/jbc.M002903200
21. Nan R, Farabella I, Schumacher F, Miller A, Gor J, Martin ACR, et al. Localisation of the major zinc-binding site of complement factor H to the SCR-6/8 domains: possible implications for age-related macular degeneration. J Mol Biol (2011) 408:714-35. doi:10.1016/j.jmb.2011.03.006
22. Nan R, Tetchner S, Rodriguez E, Pao P-J, Gor J, Lengyel I, et al. Zinc-induced self-association of complement C3b and factor H: implications for inflammation and age-related macular degeneration. J Biol Chem (2013) 288:19197-210. doi:10.1074/jbc.M113.476143
23. Nan R, Gor J, Perkins SJ. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease. J Mol Biol (2008) 375:891-900. doi:10.1016/j.jmb.2007.11.015
24. Perkins SJ, Nan R, Li K, Khan S, Miller A. Complement factor H-ligand interactions: self-association, multivalency and dissociation constants. Immunobiology (2012) 217:281-97. doi:10.1016/j.imbio.2011.10.003
25. Li K, Okemefuna AI, Gor J, Hannan JP, Asokan R, Holers VM, et al. Solution structure of the complex formed between human complement C3d and full length complement receptor type 2. J Mol Biol (2008) 384:137-50. doi:10.1016/j.jmb.2008.08.084
26. Aslam M, Perkins SJ. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J Mol Biol (2001) 309:1117-38. doi:10.1006/jmbi.2001.4720
27. Okemefuna AI, Nan R, Gor J, Perkins SJ. Electrostatic interactions contribute to the folded-back conformation of wild-type human factor H. J Mol Biol (2009) 391:98-118. doi:10.1016/j.jmb.2009.06.010
28. Wu J, Wu YQ, Ricklin D, Janssen BJ, Lambris JD, Gros P. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol (2009) 10:728-33. doi:10.1038/ni.1755
29. Pangburn MK. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology (2000) 49:149-57. doi:10.1016/S0162-3109(00)80300-8
30. Meri S, Pangburn MK. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A (1990) 87:3982-6. doi:10.1073/pnas.87.10.3982
31. Pangburn MK, Müller-Eberhard HJ. Complement C3 convertase: cell surface restriction of βIH control and generation of restriction on neuraminidase treated cells. Proc Natl Acad Sci U S A (1978) 75:2416-20. doi:10.1073/pnas.75.5.2416
32. Fernando AN, Furtado PB, Clark SJ, Gilbert HE, Day AJ, Sim RB, et al. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J Mol Biol (2007) 368:564-81. doi:10.1016/j.jmb.2007.02.038
33. Mulloy B, Khan S, Perkins SJ. The molecular architecture of heparin and heparan sulfate: recent developments in solution structural studies. Pure Appl Chem (2012) 84:65-76. doi:10.1351/PAC-CON-11-10-27
34. Li K, Gor J, Perkins SJ. Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3. Biochem J (2010) 431:63-72. doi:10.1042/BJ20100759
35. Kajander T, Lehtinen MJ, Hyvärinen S, Bhattacharjee A, Leung E, Isenman DE, et al. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc Natl Acad Sci U S A (2011) 108:2897-902. doi:10.1073/pnas.1017087108
36. Okemefuna AI, Li K, Nan R, Ormsby RJ, Sadlon T, Gordon DL, et al. Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation. J Mol Biol (2009) 391:119-35. doi:10.1016/j.jmb.2009.06.013
37. Lengyel I, Flinn JM, Peto T, Linkous DH, Cano K, Bird AC, et al. High concentration of zinc in sub-retinal pigment epithelial deposits. Exp Eye Res (2007) 84:772-80. doi:10.1016/j.exer.2006.12.015
38. Yu H, Munoz EM, Edens RE, Linhardt RJ. Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta (2005) 1726:168-76. doi:10.1016/j.bbagen.2005.08.003
39. Herbert AP, Uhrin D, Lyon M, Pangburn MK, Barlow PN. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J Biol Chem (2006) 281:16512-20. doi:10.1074/jbc.M513611200
40. Bird AC. Therapeutic targets in age-related macular disease. J Clin Invest (2010) 120:3033-41. doi:10.1172/JCI42437
41. Goodship THJ, Kavanagh D. Pulling the trigger in atypical hemolytic uremic syndrome: the role of pregnancy. J Am Soc Nephrol (2010) 21:731-2. doi:10.1681/ASN.2010030308
42. Perkins SJ, Nan R, Okemefuna AI, Li K, Khan S, Miller A. Multiple interactions of complement factor H with its ligands in solution: a progress report. Current topics on complement and eye diseases (Eds. J. D. Lambris and A. Adamis). Adv Exp Med Biol (2010) 703:25-47. doi:10.1007/978-1-4419-5635-4_3
43. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 102:7227-32. doi:10.1073/pnas.0501536102
44. Kliffen M, Mooy CM, Luider TM, Huijmans JGM, Kerkvliet S, de Jong PTVM. Identification of glycosaminoglycans in age-related macular deposits. Arch Ophthalmol (1996) 114:1009-14. doi:10.1001/archopht.1996.01100140217021
45. Pangburn MK, Rawal N, Cortes C, Alam MN, Ferreira VP, Atkinson MA. Polyanion-induced self-association of complement factor H. J Immunol (2009) 182:1061-8.
46. Saunders RE, Abarrategui-Garrido C, Frémeaux-Bacchi V, Goicoechea de Jorge E, Goodship THJ, López Trascasa M, et al. The interactive factor H-atypical haemolytic uraemic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum Mutat (2007) 28:222-34. doi:10.1002/humu.20435
47. Herbert AP, Deakin JA, Schmidt CQ, Blaum BS, Egan C, Ferreira VP, et al. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem (2007) 282:18960-8. doi:10.1074/jbc.M609636200
48. Skerka C, Lauer N, Weinberger AA, Keilhauer CN, Sühnel J, Smith R, et al. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol (2007) 44:3398-406. doi:10.1016/j.molimm.2007.06.018
49. Ormsby RJ, Ranganathan S, Tong JC, Griggs KM, Dimasi DP, Hewitt AW, et al. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 49:1763-70. doi:10.1167/iovs.07-1297
50. Clark SJ, Higman VA, Mulloy B, Perkins SJ, Lea SM, Sim RB, et al. H384 allotypic variant of factor H associated with age-related macular degeneration has different heparin-binding properties from the non-disease associated form. J Biol Chem (2006) 281:24713-20. doi:10.1074/jbc.M605083200
51. Clark SJ, Perveen R, Hakobyan S, Morgan BP, Sim RB, Bishop PN, et al. Impaired binding of the AMD-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem (2010) 285:30192-202. doi:10.1074/jbc.M110.103986
52. Yu J, Wiita P, Kawaguchi R, Honda J, Jorgensen A, Zhang K, et al. Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. Biochemistry (2007) 46:8451-61. doi:10.1021/bi700459a
53. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, Tyrrell J, et al. Structural basis for complement factor H-linked age-related macular degeneration. J Exp Med (2007) 204:2277-83. doi:10.1084/jem.20071069
54. Nan R, Ward G, Gavigan L, Miller A, Gor J, McKay AR, et al. The His402 allotype of complement Factor H show similar self-association to the Tyr402 allotype. Molec Immunol [abstract] (2010) 47:2263. doi:10.1016/j.molimm.2010.05.195